Anzu Partners, an investment firm delivering capital and strategic support to breakthrough technology companies, today announced the promotion of Josh Stiling to Principal on its investment team.

XGS Energy (“XGS”), a developer of next-generation geothermal power systems, and Baker Hughes, an energy technology company, today announced a strategic collaboration and initial order for Baker Hughes engineering services to advance XGS’s planned 150-megawatt geothermal project in New Mexico. The project, once developed, will support the delivery of clean, round-the-clock power to the Public Service Company of New Mexico’s (PNM) grid in support of Meta’s data center operations in the state.

OTI Lumionics, a leader in advanced quantum simulations and solutions for next-generation materials discovery, announces a significant breakthrough in computational chemistry. The company has successfully run its Iterative Qubit Coupled Cluster (iQCC) algorithm using NVIDIA accelerated computing, achieving a new benchmark for what’s possible with material design simulations. This innovation enables the simulation of complex molecular systems with higher efficiency, speed and accuracy than ever before.

Niron Magnetics, the leading manufacturer of rare-earth-free Iron Nitride permanent magnets, today announced that it is initiating a formal site selection process for a new high-volume manufacturing (HVM) plant in the U.S. The new plant is intended to significantly expand national production capacity for the next-generation of permanent magnets that are critical across automotive, consumer electronics, industrial, and defense sectors.

GelSight®, a pioneer in high-resolution tactile sensing technology, today announced it has been awarded a Phase II Small Business Innovation Research (SBIR) contract from the U.S. Air Force to develop a compact, rugged tactile “digital fingertip” sensor designed to enhance intelligent robotic grasping and manipulation.

ImmunoScape Pte. Ltd., an A*STAR spin-out backed by Amgen Ventures and EDBI that is developing next-generation TCR-based cancer immunotherapies, today announced the execution of a Memorandum of Understanding (MOU) with a premier NCI-designated Comprehensive Cancer Center in the United States, renowned globally for its pioneering history in cellular immunotherapy. This partnership will fast-track ImmunoScape’s “Seed and Boost” platform into the clinic. Concurrently, the company announced a strategic investment from Leonardo DiCaprio.